Sirnaomics Ltd. (HKG:2257)
Hong Kong · Delayed Price · Currency is HKD 6.54
+0.13 (2.03%)
Apr 2, 2026, 3:54 PM HKT
Sirnaomics Market Cap
Sirnaomics has a market cap or net worth of 712.2 million as of April 2, 2026. Its market cap has increased by 115.32% in one year.
Market Cap
712.20M
Enterprise Value
566.01M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.54
Market Cap Chart
Since December 30, 2021, Sirnaomics's market cap has decreased from 6.86B to 712.20M, a decrease of -89.62%. That is a compound annual growth rate of -41.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 712.20M | -12.73% |
| Dec 31, 2025 | 816.08M | 126.04% |
| Dec 31, 2024 | 361.03M | -88.38% |
| Dec 29, 2023 | 3.11B | -38.75% |
| Dec 30, 2022 | 5.07B | -36.82% |
| Dec 31, 2021 | 8.03B | 17.07% |
| Dec 30, 2021 | 6.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.63B |
| Beijing Biostar Pharmaceuticals | 1.41B |
| Transcenta Holding | 1.34B |
| Kintor Pharmaceutical | 1.29B |
| Brii Biosciences | 1.02B |
| 3D Medicines | 1.01B |
| Shanghai Bio-heart Biological Technology | 1.01B |
| Sunho Biologics | 970.43M |